Want to join the conversation?
Biopharmaceutical company $EBS said it expects 2015 revenue of $520-525MM, the midpoint of which represents 16% rise over 2014. This growth is driven by continued robust BioThrax sales, accounting for about $294MM. For 2015, $EBS expects GAAP EPS of $1.27-1.35, the midpoint of which represents 69% growth over 2014.
I haven’t seen a drop in banks like this in a long time. Looks like $WFC is still facing pressures from its sales practices scandal..!!
Helping President-elect's America first focus, $WMT set to create 10,000 retail jobs in the US in 2017.
Looks like Trump has his eyes on the $MON and Bayer merger next. He had a meeting with the CEOs and apparently got job promises from them.